Navin Fluorine International’s remarkable rise from modest beginnings to multibagger status

Navin Fluorine International’s long-term stock performance highlights the potential of patient equity investing, with a ₹1 lakh initial investment growing to over ₹2.4 crore, amid sustained momentum and solid financial growth.

Navin Fluorine International has emerged as one of the more striking examples of how patient equity investing can turn a modest sum into a fortune. The stock has climbed sharply over the long term, rewarding investors who held on through years of volatility and sector swings. On the latest reported close, the shares finished at ₹8,230 after a sharp fall, but the longer arc of the move is what has caught attention.

According to the figures cited in the report, the stock was at ₹33.99 on August 8, 2013. That means a hypothetical ₹1 lakh investment at that level would now be worth about ₹2.42 crore, before taxes and transaction costs. The implied gain of more than 24,000% explains why the shares are being described as a multibagger.

The run has not been limited to the very long term. Over the past 5 years, the stock has more than doubled, delivering a gain of about 121%, even as markets have endured plenty of turbulence. In the past 12 months, it has risen 71%, and over the last 6 months it has advanced 25%, suggesting that momentum has remained intact despite periodic corrections.

The latest weekly performance was also positive until the final session, with the share rising 7.20% across 5 trading days and adding ₹553 in value during that stretch, before ending Friday down 4.86%. The company’s market capitalisation was put at ₹42,430 crore, while its 52-week high stood at ₹8,775.50. Moneycontrol’s financial data also points to a business with solid recent revenue and profit growth, helping explain investor confidence in the chemicals maker. As always, such stock-market gains can reverse quickly, so investors are typically advised to seek professional guidance before committing fresh money.

Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.